CCM-AMI, a Polyethylene Glycol Micelle with Amifostine, as an Acute Radiation Syndrome Protectant in C57BL/6 Mice
MouseRadiationC57BL/6MaleIntravenous injection45 mg/kg90 minutes before irradiation
Model: Total-body irradiation from a 60Co source at 7.2 and 8.5 Gy delivered at a dose rate of 0.04 Gy per minute, producing acute radiation syndrome
Prophylactic CCM-Ami gave both a survival benefit and haematopoietic protection relative to excipient control and free amifostine after 7.2 and 8.5 Gy total-body irradiation, and plasma concentrations of the active metabolite WR-1065 were higher in CCM-Ami treated than amifostine treated mice, indi…
Extraction: extract · Supplied extraction confidence: 0.72. Machine-extracted fields require source verification.